Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michael C. Nielsen"'
Autor:
Amber Hickman, Joost Koetsier, Trevin Kurtanich, Michael C. Nielsen, Glenn Winn, Yunfei Wang, Salah-Eddine Bentebibel, Leilei Shi, Simone Punt, Leila Williams, Cara Haymaker, Charles B. Chesson, Faisal Fa’ak, Ana L. Dominguez, Richard Jones, Isere Kuiatse, Amy R. Caivano, Sayadeth Khounlo, Navin D. Warier, Upendra Marathi, Robert V. Market, Ronald J. Biediger, John W. Craft Jr., Patrick Hwu, Michael A. Davies, Darren G. Woodside, Peter Vanderslice, Adi Diab, Willem W. Overwijk, Yared Hailemichael
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 13 (2022)
The inability of CD8+ effector T cells (Teffs) to reach tumor cells is an important aspect of tumor resistance to cancer immunotherapy. The recruitment of these cells to the tumor microenvironment (TME) is regulated by integrins, a family of adhesion
Externí odkaz:
https://doaj.org/article/fa40e9308828487fa0c01f7b477bb940
Autor:
Derek T. Moore, Faisal Fa’ak, Manisha Singh, Tihui Fu, Michael C. Nielsen, Jason Roszik, Christina Vianden, Amber Woods, Victor H. Engelhard, Padmanee Sharma, Yared Hailemichael, Farah Hasan, Meenu Sharma, Zhimin Dai, Hiep Khong, Willem W. Overwijk, Scott M. Anthony, Zhilan Xiao, Kimberly S. Schluns, Qiuming He
Anticancer vaccination is a promising approach to increase the efficacy of cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed death ligand 1 (PD-L1) checkpoint blockade therapies. However, the landmark FDA registration trial for anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::013c8ca8895cc652b7253041891714fb
https://europepmc.org/articles/PMC5873868/
https://europepmc.org/articles/PMC5873868/